Seaport Therapeutics, Inc. (SPTX)
26.77
-1.07
(-3.84%)
USD |
NASDAQ |
Aug 27, 15:38
Seaport Therapeutics Enterprise Value : 1.222B for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 1.222B |
| August 25, 2026 | 1.061B |
| August 24, 2026 | 1.021B |
| August 21, 2026 | 1.033B |
| August 20, 2026 | 1.018B |
| August 19, 2026 | 1.039B |
| August 18, 2026 | 1.015B |
| August 17, 2026 | 1.038B |
| August 14, 2026 | 1.028B |
| August 13, 2026 | 1.001B |
| August 12, 2026 | 1.006B |
| August 11, 2026 | 982.18M |
| August 10, 2026 | 963.98M |
| August 07, 2026 | 996.10M |
| August 06, 2026 | 967.73M |
| August 05, 2026 | 927.58M |
| August 04, 2026 | 878.87M |
| August 03, 2026 | 837.11M |
| July 31, 2026 | 826.94M |
| July 30, 2026 | 819.45M |
| July 29, 2026 | 788.40M |
| July 28, 2026 | 796.97M |
| July 27, 2026 | 831.23M |
| July 24, 2026 | 861.20M |
| July 23, 2026 | 906.17M |
| Date | Value |
|---|---|
| July 22, 2026 | 871.91M |
| July 21, 2026 | 855.85M |
| July 20, 2026 | 831.76M |
| July 17, 2026 | 847.82M |
| July 16, 2026 | 776.62M |
| July 15, 2026 | 826.41M |
| July 14, 2026 | 825.87M |
| July 13, 2026 | 807.67M |
| July 10, 2026 | 886.90M |
| July 09, 2026 | 829.62M |
| July 08, 2026 | 869.77M |
| July 07, 2026 | 707.57M |
| July 06, 2026 | 768.59M |
| July 02, 2026 | 832.83M |
| July 01, 2026 | 879.94M |
| June 30, 2026 | 894.39M |
| June 29, 2026 | 1.354B |
| June 26, 2026 | 1.294B |
| June 25, 2026 | 1.184B |
| June 24, 2026 | 1.182B |
| June 23, 2026 | 1.164B |
| June 22, 2026 | 1.111B |
| June 18, 2026 | 1.121B |
| June 17, 2026 | 1.063B |
| June 16, 2026 | 1.110B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 678.50B |
| Bristol Myers Squibb Co. | 172.03B |
| Pfizer Inc. | 213.08B |
| ANI Pharmaceuticals, Inc. | 1.947B |
| Corcept Therapeutics, Inc. | 12.63B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -62.60M |
| Total Expenses (Quarterly) | 62.60M |
| EPS Diluted (Quarterly) | -1.169 |
| Earnings Yield | -8.11% |
| Normalized Earnings Yield | -8.109 |